Skip to main content
01274 442076
The Rising Tide of Type 2 Diabetes: How Primary Care Can Improve Outcomes and Workload
|
Getting your Trinity Audio player ready...
|
Type 2 diabetes is rising across England, with prevalence now at 7.0% of the adult population. For primary care teams, this means growing registers, more complex medication decisions, and increasing pressure on annual review capacity. A diabetes optimisation pharmacist helps practices respond to this challenge by creating a systematic approach to diabetes reviews and implementing NICE guidance safely and consistently. [1]
- The Scale of the Challenge
- What Does a Diabetes Optimisation Pharmacist Do?
- How Does Clinical Pharmacist-Led Optimisation Reduce Workload?
- Why is Modern Diabetes Management Focused on Cardio-Renal Protection?
Key Takeaways
- Specialist Role: This dedicated expert focuses on improving diabetes care across a PCN, driving improvements in both outcomes and efficiency.
- Guideline-Driven: Their work aligns with NICE guidelines to reduce variation and ensure evidence-based treatment, particularly around modern therapies that offer cardio-renal protection.
- Improves Outcomes: This role is key to improving HbA1c in primary care, ensuring cardio renal protection diabetes, and hitting QOF targets.
- Systematic Approach: They implement structured pathways for medication reviews, therapy escalation, and patient follow-up, creating a more resilient system.
The Scale of the Challenge
In England, while diabetes prevalence grows, national data shows that only 54.3% of patients receive all nine NICE-recommended care processes each year. [1] Closing this gap through effective diabetes annual review optimisation is one of the fastest ways to improve outcomes, ensure patient safety, and reduce the need for reactive, urgent care appointments. These gaps in care often lead to missed opportunities to intensify treatment, identify complications early, and reduce long-term cardiovascular risk.
What Does a Diabetes Optimisation Pharmacist Do?
A diabetes optimisation pharmacist is a specialist clinical pharmacist who helps primary care networks (PCNs) systematically improve care for patients with type 2 diabetes. By focusing on guideline-directed therapy and proactive case management, they help close gaps in care and improve patient outcomes. Central to this work is diabetes medication optimisation – ensuring every patient is on the right therapy at the right dose. This involves:
- Running structured medication reviews for complex patients.
- Identifying patients who need therapy escalation or optimisation.
- Implementing NICE guideline NG28 guidance, including new recommendations for SGLT2 inhibitors.
- Optimising blood pressure and lipid control to reduce cardiovascular risk.
- Ensuring the nine essential care processes are completed and acted upon.
- Reducing repeat GP appointments through proactive follow-up.
How Does Clinical Pharmacist-Led Optimisation Reduce Workload?
The primary goal of clinical pharmacist-led diabetes optimisation is to ensure every patient receives the right care at the right time, according to national standards. A structured clinical pharmacist-led diabetes optimisation pathway allows practices to standardise care and reduce variation across the register. This involves moving beyond simple annual reviews to a more dynamic and responsive model of care. A pharmacist diabetes clinic in primary care provides a dedicated setting for managing more complex patients. For example, a pharmacist diabetes clinic in primary care might prioritise patients with an HbA1c above 58 mmol/mol or those with evidence of kidney disease. By addressing diabetes medication optimisation and monitoring in a single, structured appointment, clinical pharmacists can prevent multiple follow-up GP reviews.
Why is Modern Diabetes Management Focused on Cardio-Renal Protection?
Effective diabetes management is about more than just controlling blood glucose. The modern approach, in the latest NICE guideline NG28, focuses on holistic assessments of patient risk, particularly cardiovascular and renal-health.
NICE guidance now recommends SGLT2 inhibitors earlier in the treatment pathway for many patients. Specifically to reduce the risk of complications like heart failure and chronic kidney disease. A clinical pharmacist can ensure that eligible patients are identified and offered these protective therapies through dedicated clinical pharmacist support within primary care.
“Empowering a clinical pharmacist to lead on diabetes optimisation is one of the most effective ways a PCN can drive meaningful improvements in patient care. It moves the focus from reactive treatment to proactive, guideline-led management that prevents complications and improves lives.”
Adeem Azhar, Co-Founder and Chief Executive Officer – Core Prescribing Solutions
Frequently Asked Questions
What is a diabetes optimisation pharmacist? This is a clinical pharmacist with a special interest and enhanced skills in diabetes management who works with PCNs to improve care quality, safety, and outcomes for patients with diabetes.
How does this role differ from a general practice pharmacist? While a general practice pharmacist manages a wide range of conditions, this specialist role focuses exclusively on the diabetes patient cohort, allowing for a greater depth of expertise and more systematic quality improvement.
What are the benefits for a PCN? The main benefits include improved QOF achievement, reduced variation in care, better patient outcomes (e.g., lower HbA1c), and increased practice capacity as the pharmacist takes on complex reviews.
How does this align with Structured Medication Reviews (SMRs)? This work is a core part of proactive Structured Medication Reviews (SMRs), as described in NHS England guidance on SMRs. Within a pharmacist diabetes clinic in primary care, the clinical pharmacist will conduct Level 3 medication reviews focused on diabetes therapy.
Looking for support with diabetes management?
If your PCN or practice needs to improve how it manages long-term conditions such as type 2 diabetes, our clinical pharmacist support can provide the specialist expertise you need.
[1] Diabetes profile: statistical commentary, March 2025 – GOV.UK
